Siemens Healthineers Makes AI-Based COVID-19 Severity Algorithm Available
The Atellica COVID-19 Severity Algorithm can help predict the likelihood of severe disease and multiorgan dysfunction in COVID-19 patients.
Read MorePosted by Chris Wolski | Aug 13, 2021 | Covid 19 |
The Atellica COVID-19 Severity Algorithm can help predict the likelihood of severe disease and multiorgan dysfunction in COVID-19 patients.
Read MorePosted by Chris Wolski | Aug 13, 2021 | Diagnostic Technologies |
Scientists have used CRISPR technology to identify antibodies in blood samples, which could inspire a new class of medical diagnostics.
Read MorePosted by Chris Wolski | Aug 12, 2021 | Covid 19 |
PHASE Scientific International Ltd.’s INDICAID COVID-19 Rapid Antigen Test received Emergency Use Authorization (EUA) from the FDA.
Read MorePosted by Chris Wolski | Aug 12, 2021 | Company News, Covid 19 |
Texas Children’s Hospital announced it will require all members of its workforce to be vaccinated against COVID-19.
Read MorePosted by Chris Wolski | Aug 12, 2021 | Covid 19, Flu & Respiratory Infections, Immunoassay |
GENETWORx provides a combination COVID/influenza/RSV test, and is able to provide follow-up PCR testing after a positive test in 24-48 hours.
Read More